Semnur Pharmaceuticals to go public via SPAC merger with Denali Capital in $2.5 bln deal
03/09/2024 14:10
Sept 3 (Reuters) - Semnur Pharmaceuticals, a wholly owned subsidiary of Scilex Holding Company SCLX.O , will go public via a merger with special purpose acquisition company Denali Capital Acquisition Corp in a $2.5 billion deal, the companies said on Tuesday. (Reporting by Jaiveer Singh Shekhawat in Bengaluru; Editing by Alan Barona) ((JaiveerSingh.Shekhawat@thomsonreuters.com))
Recent news on Scilex Holding
See all newsEnters Promissory Note With Vivasor For Revolving Credit Up To $20 Million, On Aug 8
Brief: Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens To List On Biconomy Exchange As Early As June 23, 2026
Brief: O+C Private Credit Wade Defendants Dispute Complaint And Statement By Scilex Holding Company
Company Enters Binding Term Sheet With Datavault Ai - SEC Filing
Company May Offer Up To $500 Million In Securities - SEC Filing